+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Thrombin Market by Type (Bovine Thrombin, Human Plasma Thrombin, Recombinant Thrombin), Form (Liquid, Powder), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 197 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5890013
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Thrombin Market size was estimated at USD 648.96 million in 2023, USD 685.05 million in 2024, and is expected to grow at a CAGR of 6.14% to reach USD 985.29 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Thrombin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Thrombin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Thrombin Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Baxter International Inc., Bayer AG, BIOFAC A/S, BioMedica Diagnostics Inc., BioPharm Laboratories, LLC, Cayman Chemical, DiaPharma Group, Inc., Grifols, S.A., Johnson & Johnson Services, Inc., Medix Biochemica USA Inc., Merck KGaA, Mochida Pharmaceutical Co., Ltd., MyBioSource, Octapharma AG, Pfizer, Inc., Prolytix, Prospec-Tany Technogene Ltd., Proteintech Group, Inc., Regen Lab SA, Rocky Mountain Biologicals, LLC., Shanghai RAAS blood products co., Ltd, Takeda Pharmaceutical Company Limited., Teleflex Incorporated., Thermo Fisher Scientific Inc., and XD BIOCHEMS LIMITED.

Market Segmentation & Coverage

This research report categorizes the Thrombin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Bovine Thrombin
    • Human Plasma Thrombin
    • Recombinant Thrombin
  • Form
    • Liquid
    • Powder
  • End-User
    • Hospitals & Clinics
    • Medical Research & Academic Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Thrombin Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Thrombin Market?
  3. What are the technology trends and regulatory frameworks in the Thrombin Market?
  4. What is the market share of the leading vendors in the Thrombin Market?
  5. Which modes and strategic moves are suitable for entering the Thrombin Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Thrombin Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of surgical procedures and need for thrombin hemostatic agents
5.1.1.2. Expanding utilization of thrombin as a binding agent for meats
5.1.2. Restraints
5.1.2.1. Complex production process of thrombin
5.1.3. Opportunities
5.1.3.1. Expanding drug development activities promoting the usage of thrombin
5.1.3.2. Advancements in the functionalities of thrombin
5.1.4. Challenges
5.1.4.1. Major health risks associated with excessive usage of thrombin
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Thrombin Market, by Type
6.1. Introduction
6.2. Bovine Thrombin
6.3. Human Plasma Thrombin
6.4. Recombinant Thrombin
7. Thrombin Market, by Form
7.1. Introduction
7.2. Liquid
7.3. Powder
8. Thrombin Market, by End-User
8.1. Introduction
8.2. Hospitals & Clinics
8.3. Medical Research & Academic Institutes
9. Americas Thrombin Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Thrombin Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Thrombin Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Baxter International Inc.
13.1.3. Bayer AG
13.1.4. BIOFAC A/S
13.1.5. BioMedica Diagnostics Inc.
13.1.6. BioPharm Laboratories, LLC
13.1.7. Cayman Chemical
13.1.8. DiaPharma Group, Inc.
13.1.9. Grifols, S.A.
13.1.10. Johnson & Johnson Services, Inc.
13.1.11. Medix Biochemica USA Inc.
13.1.12. Merck KGaA
13.1.13. Mochida Pharmaceutical Co., Ltd.
13.1.14. MyBioSource
13.1.15. Octapharma AG
13.1.16. Pfizer, Inc.
13.1.17. Prolytix
13.1.18. Prospec-Tany Technogene Ltd.
13.1.19. Proteintech Group, Inc.
13.1.20. Regen Lab SA
13.1.21. Rocky Mountain Biologicals, LLC.
13.1.22. Shanghai RAAS blood products co., Ltd
13.1.23. Takeda Pharmaceutical Company Limited.
13.1.24. Teleflex Incorporated.
13.1.25. Thermo Fisher Scientific Inc.
13.1.26. XD BIOCHEMS LIMITED
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. THROMBIN MARKET RESEARCH PROCESS
FIGURE 2. THROMBIN MARKET SIZE, 2023 VS 2030
FIGURE 3. THROMBIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. THROMBIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. THROMBIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. THROMBIN MARKET DYNAMICS
FIGURE 7. THROMBIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. THROMBIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. THROMBIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 10. THROMBIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. THROMBIN MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. THROMBIN MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES THROMBIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES THROMBIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. THROMBIN MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. THROMBIN MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. THROMBIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. THROMBIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THROMBIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. THROMBIN MARKET SIZE, BY BOVINE THROMBIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. THROMBIN MARKET SIZE, BY HUMAN PLASMA THROMBIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. THROMBIN MARKET SIZE, BY RECOMBINANT THROMBIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 10. THROMBIN MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. THROMBIN MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 13. THROMBIN MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. THROMBIN MARKET SIZE, BY MEDICAL RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS THROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. CANADA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. CANADA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 27. CANADA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. MEXICO THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. MEXICO THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 30. MEXICO THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES THROMBIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC THROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. CHINA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. CHINA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 44. CHINA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. INDIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. INDIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 47. INDIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. JAPAN THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. JAPAN THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 53. JAPAN THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. THAILAND THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. THAILAND THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 71. THAILAND THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. DENMARK THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. DENMARK THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 81. DENMARK THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. EGYPT THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. EGYPT THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 84. EGYPT THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. FINLAND THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. FINLAND THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 87. FINLAND THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. FRANCE THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. FRANCE THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 90. FRANCE THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. GERMANY THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 93. GERMANY THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. ITALY THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. ITALY THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 99. ITALY THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. NORWAY THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. NORWAY THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 108. NORWAY THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. POLAND THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. POLAND THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 111. POLAND THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. QATAR THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. QATAR THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 114. QATAR THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SPAIN THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SPAIN THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 126. SPAIN THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. TURKEY THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. TURKEY THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 135. TURKEY THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM THROMBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM THROMBIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM THROMBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. THROMBIN MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 143. THROMBIN MARKET SHARE, BY KEY PLAYER, 2023
TABLE 144. THROMBIN MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Baxter International Inc.
  • Bayer AG
  • BIOFAC A/S
  • BioMedica Diagnostics Inc.
  • BioPharm Laboratories, LLC
  • Cayman Chemical
  • DiaPharma Group, Inc.
  • Grifols, S.A.
  • Johnson & Johnson Services, Inc.
  • Medix Biochemica USA Inc.
  • Merck KGaA
  • Mochida Pharmaceutical Co., Ltd.
  • MyBioSource
  • Octapharma AG
  • Pfizer, Inc.
  • Prolytix
  • Prospec-Tany Technogene Ltd.
  • Proteintech Group, Inc.
  • Regen Lab SA
  • Rocky Mountain Biologicals, LLC.
  • Shanghai RAAS blood products co., Ltd
  • Takeda Pharmaceutical Company Limited.
  • Teleflex Incorporated.
  • Thermo Fisher Scientific Inc.
  • XD BIOCHEMS LIMITED

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 685.05 Million
Forecasted Market Value ( USD ) by 2030 $ 985.29 Million
Compound Annual Growth Rate6.1%
Regions CoveredGlobal

Related Topics

Related Reports

Thrombin - Global Strategic Business Report - Product Image

Thrombin - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Thrombin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Thrombin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 91 Pages
  • Global
From
Thrombin Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology - Product Image

Thrombin Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology

  • Report
  • 98 Pages
  • Global
From
Factor IIa (Thrombin) Inhibitor - Pipeline Insight, 2024 - Product Image

Factor IIa (Thrombin) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • 120 Pages
  • Global
From
XARELTO Market Size, Forecast, and Market Insight - 2032 - Product Image

XARELTO Market Size, Forecast, and Market Insight - 2032

  • Report
  • 30 Pages
  • Global
From

About the Thrombin Market

Thrombin is a hematological drug used to treat bleeding disorders. It is a naturally occurring enzyme in the body that helps to form blood clots. Thrombin is used to treat a variety of conditions, including hemophilia, deep vein thrombosis, and pulmonary embolism. It is also used to help control bleeding during surgery. Thrombin is available in both injectable and topical forms. The injectable form is used to treat more serious conditions, while the topical form is used to treat minor cuts and scrapes. The thrombin market is highly competitive, with a number of companies offering products. Some of the major players in the market include Pfizer, Novo Nordisk, Bayer, and Sanofi. Other companies in the market include CSL Behring, Grifols, and Kedrion Biopharma. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.